世界のメトホルミン薬市場レポート2020年

【英語タイトル】Global Metformin Drugs Sales Market Report 2020

QYResearchが出版した調査資料(QYR20JN02438)・商品コード:QYR20JN02438
・発行会社(調査会社):QYResearch
・発行日:2020年6月
・ページ数:148
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥624,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥832,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のメトホルミン薬市場について種類別(50錠、100錠、その他)、用途別(病院、薬局)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・メトホルミン薬市場の概要
・世界の主要地域別メトホルミン薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のメトホルミン薬市場規模2015-2026:種類別(50錠、100錠、その他)
・世界のメトホルミン薬市場規模2015-2026:用途別(病院、薬局)
・メトホルミン薬の北米市場規模2015-2020
・メトホルミン薬のヨーロッパ市場規模2015-2020
・メトホルミン薬の中国市場規模2015-2020
・メトホルミン薬の日本市場規模2015-2020
・メトホルミン薬の東南アジア市場規模2015-2020
・メトホルミン薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Novartis、Apotex、Mylan、Mallinckrodt、Teva Pharmaceuticals、Alkem、Dr. Reddy’s Laboratories、Atlas Pharmaceuticals、Sun Pharmaceutical Industries、Torrent Pharmaceuticals、Bristol-Myers Squibb)
・メトホルミン薬の製造コスト分析
・販売チャネル、流通業者、顧客
・メトホルミン薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

A recently published report by QY Research titled Global Metformin Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Metformin Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Metformin Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Metformin Drugs industry.
Based on our recent survey, we have several different scenarios about the Metformin Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Metformin Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Metformin Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Metformin Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Metformin Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Metformin Drugs market. The report also includes nautical information, where it shows Metformin Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Metformin Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Metformin Drugs market.
Geographical Analysis:
Based on region, the global Metformin Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Metformin Drugs market are
Novartis
Apotex
Mylan
Mallinckrodt
Teva Pharmaceuticals
Alkem
Dr. Reddy’s Laboratories
Atlas Pharmaceuticals
Sun Pharmaceutical Industries
Torrent Pharmaceuticals
Bristol-Myers Squibb
Segment by Type
50 Tablets
100 Tablets
Other
Segment by Application
Hospital
Drugs Stores
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Metformin Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Metformin Drugs market.
• The market share of the global Metformin Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Metformin Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Metformin Drugs market.

【レポートの目次】

1 Metformin Drugs Market Overview
1.1 Metformin Drugs Product Scope
1.2 Metformin Drugs Segment by Type
1.2.1 Global Metformin Drugs Sales by Type (2020-2026)
1.2.2 50 Tablets
1.2.3 100 Tablets
1.2.4 Other
1.3 Metformin Drugs Segment by Application
1.3.1 Global Metformin Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Metformin Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Metformin Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Metformin Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Metformin Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Metformin Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Metformin Drugs Industry
1.5.1.1 Metformin Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Metformin Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Metformin Drugs Players to Combat Covid-19 Impact

2 Metformin Drugs Estimate and Forecast by Region
2.1 Global Metformin Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Metformin Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Metformin Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Metformin Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Metformin Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Metformin Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Metformin Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Metformin Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Metformin Drugs Estimates and Projections (2015-2026)
2.4.3 China Metformin Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Metformin Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Metformin Drugs Estimates and Projections (2015-2026)
2.4.6 India Metformin Drugs Estimates and Projections (2015-2026)
3 Global Metformin Drugs Competition Landscape by Players
3.1 Global Top Metformin Drugs Players by Sales (2015-2020)
3.2 Global Top Metformin Drugs Players by Revenue (2015-2020)
3.3 Global Metformin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metformin Drugs as of 2019)
3.4 Global Metformin Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Metformin Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Metformin Drugs Players (Opinion Leaders)
4 Global Metformin Drugs Market Size by Type
4.1 Global Metformin Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Metformin Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Metformin Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Metformin Drugs Price by Type (2014-2020)
4.2 Global Metformin Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Metformin Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Metformin Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Metformin Drugs Price Forecast by Type (2021-2026)
5 Global Metformin Drugs Market Size by Application
5.1 Global Metformin Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Metformin Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Metformin Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Metformin Drugs Price by Application (2015-2020)
5.2 Global Metformin Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Metformin Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Metformin Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Metformin Drugs Price Forecast by Application (2021-2026)

3 North America Metformin Drugs Market Facts & Figures
3.2 North America Metformin Drugs Sales Market Share by Company (2015-2020)
3.3 North America Metformin Drugs Sales Market Share by Type (2015-2020)
3.4 North America Metformin Drugs Sales Market Share by Application (2015-2020)

4 Europe Metformin Drugs Market Facts & Figures
4.2 Europe Metformin Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Metformin Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Metformin Drugs Sales Market Share by Application (2015-2020)

5 China Metformin Drugs Market Facts & Figures
5.2 China Metformin Drugs Sales Market Share by Company (2015-2020)
5.3 China Metformin Drugs Sales Market Share by Type (2015-2020)
5.4 China Metformin Drugs Sales Market Share by Application (2015-2020)

6 Japan Metformin Drugs Market Facts & Figures
6.2 Japan Metformin Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Metformin Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Metformin Drugs Sales Market Share by Application (2015-2020)

7 Southeast Asia Metformin Drugs Market Facts & Figures
7.2 Southeast Asia Metformin Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Metformin Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Metformin Drugs Sales Market Share by Application (2015-2020)

8 India Metformin Drugs Market Facts & Figures
8.2 India Metformin Drugs Sales Market Share by Company (2015-2020)
8.3 India Metformin Drugs Sales Market Share by Type (2015-2020)
8.4 India Metformin Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Metformin Drugs Business
12.1 Novartis
12.1.1 Novartis Metformin Drugs Corporation Information
12.1.2 Novartis Metformin Drugs Business Overview and Total Revenue
12.1.3 Novartis Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Metformin Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Apotex
12.2.1 Apotex Metformin Drugs Corporation Information
12.2.2 Apotex Metformin Drugs Business Overview and Total Revenue
12.2.3 Apotex Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Apotex Metformin Drugs Products Offered
12.2.5 Apotex Recent Development
12.3 Mylan
12.3.1 Mylan Metformin Drugs Corporation Information
12.3.2 Mylan Metformin Drugs Business Overview and Total Revenue
12.3.3 Mylan Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Metformin Drugs Products Offered
12.3.5 Mylan Recent Development
12.4 Mallinckrodt
12.4.1 Mallinckrodt Metformin Drugs Corporation Information
12.4.2 Mallinckrodt Metformin Drugs Business Overview and Total Revenue
12.4.3 Mallinckrodt Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mallinckrodt Metformin Drugs Products Offered
12.4.5 Mallinckrodt Recent Development
12.5 Teva Pharmaceuticals
12.5.1 Teva Pharmaceuticals Metformin Drugs Corporation Information
12.5.2 Teva Pharmaceuticals Metformin Drugs Business Overview and Total Revenue
12.5.3 Teva Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Pharmaceuticals Metformin Drugs Products Offered
12.5.5 Teva Pharmaceuticals Recent Development
12.6 Alkem
12.6.1 Alkem Metformin Drugs Corporation Information
12.6.2 Alkem Metformin Drugs Business Overview and Total Revenue
12.6.3 Alkem Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Alkem Metformin Drugs Products Offered
12.6.5 Alkem Recent Development
12.7 Dr. Reddy’s Laboratories
12.7.1 Dr. Reddy’s Laboratories Metformin Drugs Corporation Information
12.7.2 Dr. Reddy’s Laboratories Metformin Drugs Business Overview and Total Revenue
12.7.3 Dr. Reddy’s Laboratories Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dr. Reddy’s Laboratories Metformin Drugs Products Offered
12.7.5 Dr. Reddy’s Laboratories Recent Development
12.8 Atlas Pharmaceuticals
12.8.1 Atlas Pharmaceuticals Metformin Drugs Corporation Information
12.8.2 Atlas Pharmaceuticals Metformin Drugs Business Overview and Total Revenue
12.8.3 Atlas Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Atlas Pharmaceuticals Metformin Drugs Products Offered
12.8.5 Atlas Pharmaceuticals Recent Development
12.9 Sun Pharmaceutical Industries
12.9.1 Sun Pharmaceutical Industries Metformin Drugs Corporation Information
12.9.2 Sun Pharmaceutical Industries Metformin Drugs Business Overview and Total Revenue
12.9.3 Sun Pharmaceutical Industries Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sun Pharmaceutical Industries Metformin Drugs Products Offered
12.9.5 Sun Pharmaceutical Industries Recent Development
12.10 Torrent Pharmaceuticals
12.10.1 Torrent Pharmaceuticals Metformin Drugs Corporation Information
12.10.2 Torrent Pharmaceuticals Metformin Drugs Business Overview and Total Revenue
12.10.3 Torrent Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Torrent Pharmaceuticals Metformin Drugs Products Offered
12.10.5 Torrent Pharmaceuticals Recent Development
12.11 Bristol-Myers Squibb
12.11.1 Bristol-Myers Squibb Metformin Drugs Corporation Information
12.11.2 Bristol-Myers Squibb Metformin Drugs Business Overview and Total Revenue
12.11.3 Bristol-Myers Squibb Metformin Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bristol-Myers Squibb Metformin Drugs Products Offered
12.11.5 Bristol-Myers Squibb Recent Development

13 Metformin Drugs Manufacturing Cost Analysis
13.1 Metformin Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Metformin Drugs
13.4 Metformin Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Metformin Drugs Distributors List
14.3 Metformin Drugs Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Metformin Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Metformin Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Metformin Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Metformin Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Metformin Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Metformin Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Metformin Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Metformin Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Metformin Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Metformin Drugs Revenue Share by Region (2015-2020)
Table 13. Global Metformin Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Metformin Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Metformin Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Metformin Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Metformin Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Metformin Drugs Sales Share by Company (2015-2020)
Table 19. Global Metformin Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Metformin Drugs Revenue Share by Company (2015-2020)
Table 21. Global Metformin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metformin Drugs as of 2019)
Table 22. Global Metformin Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Metformin Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Metformin Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Metformin Drugs Players
Table 27. Global Metformin Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Metformin Drugs Sales Share by Type (2015-2020)
Table 29. Global Metformin Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Metformin Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Metformin Drugs Sales Share by Type (2021-2026)
Table 32. Global Metformin Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Metformin Drugs Revenue Share by Type (2021-2026)
Table 34. Global Metformin Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Metformin Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Metformin Drugs Sales Share by Application (2015-2020)
Table 37. Global Metformin Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Metformin Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Metformin Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Metformin Drugs Sales Share by Application (2021-2026)
Table 41. Global Metformin Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Metformin Drugs Revenue Share by Application (2021-2026)
Table 43. Global Metformin Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Metformin Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Metformin Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Metformin Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Metformin Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Metformin Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Metformin Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Metformin Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Metformin Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Metformin Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Metformin Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Metformin Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Metformin Drugs Sales Market Share by Type (2015-2020)
Table 56. China Metformin Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Metformin Drugs Sales Market Share by Company (2015-2020)
Table 58. China Metformin Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Metformin Drugs Sales Market Share by Type (2015-2020)
Table 60. China Metformin Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Metformin Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Metformin Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Metformin Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Metformin Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Metformin Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Metformin Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Metformin Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Metformin Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Metformin Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Metformin Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Metformin Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Metformin Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Metformin Drugs Sales Market Share by Application (2015-2020)
Table 74. India Metformin Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Metformin Drugs Sales Market Share by Company (2015-2020)
Table 76. India Metformin Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Metformin Drugs Sales Market Share by Type (2015-2020)
Table 78. India Metformin Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Metformin Drugs Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novartis Metformin Drugs Product
Table 84. Novartis Recent Development
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Apotex Metformin Drugs Product
Table 89. Apotex Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Mylan Metformin Drugs Product
Table 94. Mylan Recent Development
Table 95. Mallinckrodt Corporation Information
Table 96. Mallinckrodt Description and Business Overview
Table 97. Mallinckrodt Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Mallinckrodt Metformin Drugs Product
Table 99. Mallinckrodt Recent Development
Table 100. Teva Pharmaceuticals Corporation Information
Table 101. Teva Pharmaceuticals Description and Business Overview
Table 102. Teva Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Teva Pharmaceuticals Metformin Drugs Product
Table 104. Teva Pharmaceuticals Recent Development
Table 105. Alkem Corporation Information
Table 106. Alkem Description and Business Overview
Table 107. Alkem Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Alkem Metformin Drugs Product
Table 109. Alkem Recent Development
Table 110. Dr. Reddy’s Laboratories Corporation Information
Table 111. Dr. Reddy’s Laboratories Description and Business Overview
Table 112. Dr. Reddy’s Laboratories Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Dr. Reddy’s Laboratories Metformin Drugs Product
Table 114. Dr. Reddy’s Laboratories Recent Development
Table 115. Atlas Pharmaceuticals Corporation Information
Table 116. Atlas Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Atlas Pharmaceuticals Description and Business Overview
Table 118. Atlas Pharmaceuticals Metformin Drugs Product
Table 119. Atlas Pharmaceuticals Recent Development
Table 120. Sun Pharmaceutical Industries Corporation Information
Table 121. Sun Pharmaceutical Industries Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Sun Pharmaceutical Industries Description and Business Overview
Table 123. Sun Pharmaceutical Industries Metformin Drugs Product
Table 124. Sun Pharmaceutical Industries Recent Development
Table 125. Torrent Pharmaceuticals Corporation Information
Table 126. Torrent Pharmaceuticals Description and Business Overview
Table 127. Torrent Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Torrent Pharmaceuticals Metformin Drugs Product
Table 129. Torrent Pharmaceuticals Recent Development
Table . Bristol-Myers Squibb Corporation Information
Table . Bristol-Myers Squibb Description and Business Overview
Table . Bristol-Myers Squibb Metformin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Bristol-Myers Squibb Metformin Drugs Product
Table . Bristol-Myers Squibb Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Metformin Drugs Distributors List
Table 138. Metformin Drugs Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Metformin Drugs Product Picture
Figure 2. Global Metformin Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Metformin Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Drugs Stores Examples
Figure 8. Global Metformin Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Metformin Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Metformin Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Metformin Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Metformin Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Metformin Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Metformin Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Metformin Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Metformin Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Metformin Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Metformin Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Metformin Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Metformin Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Metformin Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Metformin Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Metformin Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Metformin Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Metformin Drugs Players Market Share by Revenue in Metformin Drugs 2015 & 2019
Figure 26. Metformin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Metformin Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Metformin Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Metformin Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Metformin Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Metformin Drugs Sales Market Share by Type in 2019
Figure 32. United States Metformin Drugs Sales Market Share by Type in 2019
Figure 33. Europe Metformin Drugs Sales Market Share by Company in 2019
Figure 34. Europe Metformin Drugs Sales Market Share by Type in 2019
Figure 35. Europe Metformin Drugs Sales Market Share by Application in 2019
Figure 36. China Metformin Drugs Sales Market Share by Company in 2019
Figure 37. China Metformin Drugs Sales Market Share by Type in 2019
Figure 38. China Metformin Drugs Sales Market Share by Application in 2019
Figure 39. Japan Metformin Drugs Sales Market Share by Company in 2019
Figure 40. Japan Metformin Drugs Sales Market Share by Type in 2019
Figure 41. Japan Metformin Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Metformin Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Metformin Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Metformin Drugs Sales Market Share by Application in 2019
Figure 45. India Metformin Drugs Sales Market Share by Company in 2019
Figure 46. India Metformin Drugs Sales Market Share by Type in 2019
Figure 47. India Metformin Drugs Sales Market Share by Application in 2019
Figure 48. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Alkem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Atlas Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Torrent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Metformin Drugs
Figure 61. Manufacturing Process Analysis of Metformin Drugs
Figure 62. Metformin Drugs Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Novartis、Apotex、Mylan、Mallinckrodt、Teva Pharmaceuticals、Alkem、Dr. Reddy’s Laboratories、Atlas Pharmaceuticals、Sun Pharmaceutical Industries、Torrent Pharmaceuticals、Bristol-Myers Squibb

【レポートのキーワード】

メトホルミン薬、50錠、100錠、病院、薬局

★調査レポート[世界のメトホルミン薬市場レポート2020年] (コード:QYR20JN02438)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のメトホルミン薬市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆